Cantor Fitzgerald Reiterates Overweight on Humana, Maintains $597 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Humana (NYSE:HUM) and maintained a price target of $597.
November 02, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Humana's stock rating has been reiterated as Overweight by Cantor Fitzgerald, with a maintained price target of $597.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for Humana. This could potentially lead to an increase in the stock's price in the short term. The maintained price target of $597 also suggests that the analyst believes the stock is undervalued at its current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100